SOURCE: Xtalks

Xtalks Webinars

September 08, 2017 07:00 ET

Tactics for Successful Patient Recruitment in Alzheimer's Clinical Studies

TORONTO, ON--(Marketwired - September 08, 2017) - In an Xtalks webinar scheduled for Thursday, September 21, 2017 at 11am EDT (4pm BSK/UK), industry expert William A Holt, DO, Executive Director of Scientific Affairs for Neurosciences at PRA Health Sciences will discuss tactics for successful patient recruitment in Alzheimer's Clinical Studies.

Some upcoming treatments for Alzheimer's Disease, particularly those of a preventative nature, rely upon participation in clinical research from individuals diagnosed with either Prodromal Alzheimer's Disease (pAD) or Minimal Cognitive Impairment (MCI) at risk of developing AD. Identifying these individuals paves the way for early intervention with the goal of completely slowing or halting the onset of Alzheimer's. Whilst this patient population remains functionally independent, without the challenges of recruiting those with severe memory impairment, these clinical trials can be difficult to recruit in part, due to biomarker eligibility requirements which may include PET imaging and/or cerebrospinal fluid assessments. Screening of subjects is therefore costly and time-consuming, with a significant screen fail rate.

According to the Alzheimer's Association, at least 50,000 volunteers will be needed across 500 studies that are either recruiting or preparing to recruit for clinical trials. In this webinar, the speaker will consider strategies for timely patient recruitment and retention for Alzheimer's clinical trials. In addition, the speaker will discuss guidelines for, and technologies to support patient recruitment. Examples of these methods include social listening to ensure clinical research messaging is resonating with target groups, embracing their needs and concerns, or using big data to facilitate site selection.

The speaker will discuss guidelines for and technologies to support patient recruitment:

  • Understand current Alzheimer's disease targets for next generation therapies
  • Learn how use of technologies can spur interest within patient communities
  • Explore possibilities surrounding digital screening and virtual reporting tools
  • Ensure your subjects concerns are fully embraced through social listening
  • Make informed decisions on site selection via data intelligence

To learn more information about this complimentary event visit: Tactics for Successful Patient Recruitment in Alzheimer's Clinical Studies

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/9/7/11G145134/Images/PRA_Health_Logo_250-116016051903.jpg

Contact Information